Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →
BioCurie raised $1 million in seed funding for its AI-driven cell therapy platform through Delaware's SSBCI program. The funds will support key hires and advances to secure its first major customer.
Aug 19, 2026•about 3 hours ago
Description
BioCurie raised $1 million in seed capital in August 2026 through Delaware's Accelerator & Seed Capital Program. The funding will support key hires and advances to the platform aimed at cell and gene therapy manufacturing. The program is part of the State Small Business Credit Initiative, helping to build Delaware's biotechnology ecosystem.
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months